genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
FDA review
News
Verona Pharma – Ensifentrine
Cancer
FDA Approves Guardant Test as First Pan-Cancer Liquid Biopsy, CDx for AstraZeneca’s Tagrisso
Insights
Not If. When: Metabolomics’ Impact in Cancer Treatments May Be Just around the Corner
Featured
Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10
Industry News
New Studies Link Alirocumab to Reduced CV Disease Risk
Drug Discovery
Biogen Wins Full EC Approval for MS Drug Fampyra
Drug Discovery
Valeo Negotiates Canadian Rights to Safinamide from Zambon
Drug Discovery
Dynavax Eliminates 38% of Its Workforce, Refocuses on Oncology
News
Binge Eating Suppressed by Serotonin 2C Receptor
Insights
Biospecimen Parameters Keep Pace with Precision Medicine
1
2
3
4
...
10
Page 3 of 10
Scroll Up
Scroll Up
